Jiangsu Hengrui Pharmaceutical Group

New Business

Time for investors to balance China shares as Hong Kong discount narrows, HSBC says

Investors should shift to a balanced view of Chinese shares traded on the mainland and in Hong Kong, as the…

Read More »
Back to top button